Drug intelligence / Profile preview

Digihaler

Development stage
Unknown
Lead developer
Teva Pharmaceutical Industries
Modality
Small Molecules
Administration
Inhalation
01

Overview

Digihaler refers to a family of prescription digital inhalers equipped with built-in electronic modules that detect, record, and store data on inhaler use for transmission to a mobile app. The main products under the "Digihaler" brand are: - **ProAir Digihaler** (albuterol sulfate): A quick-relief (rescue) dry powder inhaler containing albuterol sulfate, a short-acting beta2-adrenergic agonist. It is indicated for the treatment or prevention of bronchospasm in patients with reversible obstructive airway disease and for prevention of exercise-induced bronchospasm[1][4][6]. - **AirDuo Digihaler** (fluticasone propionate and salmeterol): A combination dry powder inhaler containing fluticasone propionate (an inhaled corticosteroid) and salmeterol (a long-acting beta2-adrenergic agonist). It is indicated for maintenance treatment of asthma in patients aged 12 years and older[3][5][7]. - **ArmonAir Digihaler** (fluticasone propionate): An inhaled corticosteroid-only product used as long-term maintenance therapy for asthma in patients 12 years and older[2][8]. All these products feature digital connectivity to help track medication usage but differ by active ingredients and clinical indications.

Brand names
DigihalerProAir DigihalerAirDuo DigihalerArmonAir Digihaler
02

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on Digihaler.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digihaler.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call